Huminig, Ayisha .
HRN: 27-31-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2025
CEFUROXIME 750MG (VIAL)
11/25/2025
12/02/2025
IV
430 Mg
Q 8 Hours
UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes